PTHS
Pelthos Therapeutics Inc.
20.60$
+1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -206.0% | -66.6% | -120.4% | -49.1% | -97.7% | |
| – | – | – | – | – | – | – | 15.4% | 13.0% | 14.4% | 8.9% | 12.3% | |
| – | – | – | – | – | – | – | 37.3% | 19.2% | 17.5% | 17.7% | 21.3% | |
| – | – | – | – | – | – | – | -68.0% | -44.9% | -22.3% | 37.0% | -13.7% | |
| – | – | – | – | – | – | – | 0.0% | 1.1% | 1.8% | 0.0% | 0.7% | |
| – | – | – | – | – | – | – | 37.3% | -85.2% | -1.8% | 0.0% | -12.5% | |
| – | – | – | – | – | – | – | 0.0% | 0.0% | – | – | – | |
| – | – | – | – | – | – | – | 359.3% | -101.0% | 252.4% | 0.0% | 103.1% | |
| – | – | – | – | – | – | – | 360.4% | 191.9% | 252.4% | 0.0% | 166.8% | |
| – | – | – | – | – | – | – | 190.7% | 40.2% | 130.2% | -49.1% | 56.4% | |
| – | – | – | – | – | – | – | -206.0% | -67.6% | -122.1% | -49.1% | -98.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.